Becton Dickinson EVP Michael Garrison Sells 1,100 Shares Under 10b5-1 Plan

Michael David Garrison, Executive Vice President & President of Medical Essentials & BioPharm at Becton Dickinson & Co (BDX), sold 1,100 shares of common stock on June 24, 2026, at a price of $145.66 per share. The transaction was executed pursuant to a Rule 10b5-1 trading plan that Garrison adopted on February 18, 2026. Following this sale, Garrison's remaining ownership position in BDX common stock stands at 13,172 shares. The filing indicates the transaction was made under a pre-established trading plan, which allows corporate insiders to schedule stock transactions in advance to avoid concerns about trading on non-public information. The sale represents a routine disposition of shares by a company executive under a structured trading arrangement.